Welcome to our dedicated page for Greenlight Capital Re SEC filings (Ticker: GLRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Greenlight Capital Re’s filings combine insurance math with hedge-fund moves—no wonder a single 10-K can stretch past 250 pages. If you are trying to locate catastrophe exposure tables, track David Einhorn’s Form 4 purchases, or compare quarterly underwriting margins, the raw documents can feel overwhelming.
StockTitan solves this. Our AI reads every line the moment a document hits EDGAR, then delivers plain-English answers to the questions investors actually ask—like “What changed in Greenlight Capital Re’s combined ratio?” or “How did the investment portfolio perform this quarter?” You’ll find:
- Greenlight Capital Re quarterly earnings report 10-Q filing annotated with segment results.
- Greenlight Capital Re insider trading Form 4 transactions, updated in real-time, plus alerts on executive stock transactions Form 4.
- Greenlight Capital Re annual report 10-K simplified to highlight catastrophe limits, float size, and reserve strength.
- Greenlight Capital Re proxy statement executive compensation insights, including incentive metrics tied to book value growth.
- Greenlight Capital Re 8-K material events explained—capital raises, sizable loss events, or investment portfolio shifts.
Need quick answers? Type natural questions such as “understanding Greenlight Capital Re SEC documents with AI” or “Greenlight Capital Re earnings report filing analysis” into our search bar. StockTitan’s expert summaries, ratio calculators, and keyword jump-links let you monitor Form 4 insider transactions real-time, compare quarter-over-quarter results, and spot disclosure changes before the market reacts. Comprehensive coverage, AI clarity—everything you require to turn complex reinsurance filings into actionable knowledge.
Greenlight Capital Re (NASDAQ:GLRE) director Ian Isaacs filed a Form 4 reporting the open-market sale of 13,000 ordinary shares on 25 June 2025 at a weighted-average price of $14.9227, for proceeds of roughly $195 thousand.
The transaction equals about 9.7 % of Isaacs’ 134,484-share position before the sale. Following the disposition, he holds 71,484 shares directly and 50,000 shares indirectly through a living trust and IRA, totaling 121,484 shares.
No derivative trades or 10b5-1 plan were disclosed, and the transaction code “S” confirms an open-market sale. Investors often view insider selling of this magnitude as a modest negative sentiment indicator.